Personalized cancer vaccine shows promise in early trial
NCT ID NCT06175221
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This trial tested a personalized cancer vaccine made from a patient's own tumor cells. It aimed to see if the vaccine could slow tumor growth, improve survival, and trigger an immune response. The study included 63 adults with various solid tumors, but was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Southside Medical Center
Greenville, South Carolina, 29615, United States
Conditions
Explore the condition pages connected to this study.